White House Considers Withholding Federal Money to Pressure People to Take Vaccine

The White House is reportedly considering withholding federal dollars to private business as part of its latest push to get more Americans to take the coronavirus vaccine.

“If the Biden administration goes forward with the plans, it would amount to a dramatic escalation in the effort to vaccinate the roughly 90 million Americans who are eligible for shots but who have refused or have been unable to get them,” the Washington Post reported.

“The effort could apply to institutions as varied as long-term-care facilities, cruise ships and universities, potentially impacting millions of Americans, the Post continued, “according to the people, who spoke on the condition of anonymity to discuss sensitive conversations.”

The White House issued a statement to Fox News neither confirming nor denying the Posts‘ report.

“As we always are, the administration is discussing a host of different measures we can continue to boost vaccinations across the country,” the White House said. “Any reported ideas under consideration are in early conversations and pre-decisional. There are no imminent policy decisions as to preview at this time.”- READ MORE

https://paine.tv/reports-white-house-considers-withholding-federal-money-to-pressure-people-to-take-vaccine/

Covid19Crusher @Covid19Crusher

Safe and generic anti-cough Ambroxol performs very strongly in vitro against Sars-Cov-2, via a mechanism that could be identical to Fluvoxamine (FIASMA).

OTC in many countries. Can be obtained through bromhexine syrups as well.

Great read.

https://www.sciencedirect.com/science/article/pii/S0021925821004907

Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells

Discussion

The present studies demonstrate that ambroxol prevents the entry of pp-VSV-SARS-CoV-2 spike into cultured epithelial cells as well as freshly isolated human nasal epithelial cells ex vivo (Fig. 7). Most importantly, inhalation of ambroxol was sufficient to reduce the activity of the acid sphingomyelinase in nasal epithelial cells in vivo and prevent an infection with pp-VSV-SARS-CoV-2 spike of nasal epithelial cells ex vivo. The inhalation experiments used standard concentrations of ambroxol that are also used for treatment of patients. These concentrations were sufficient to reduce acid sphingomyelinase activity in nasal epithelial cells in vivo, as shown here. Thus, clinically used concentrations should be sufficient to prevent infection with pp-VSV-SARS-CoV-2 spike. We inhaled an approximately 20 mM solution of ambroxol. Since 20 to 25 μM ambroxol is sufficient to block infection with pp-VSV-SARS-CoV-2, we expect a very broad therapeutic window.

https://t.me/worlddoctorsalliance/8387

🔥🔥🔥🔥🔥🔥

MUST WATCH

Judy Mikovits

Most important video ever - never take a shot again. Covid was injected into people with the flu shot and the variants with the Covid shots

https://www.brighteon.com/dc43ea4a-e64b-42a4-8737-1efb436751b5

posted yesterday, no date on video

but important info about where the fake vaxxes came from

references Dr David Martin, whose been out a lot very recently

JM - "It's a monkey virus"

"The spike protein is the disease-causing agent."

46 minutes